Contradictions in Corporate Social Responsibility
The pharmaceutical industry and medicines for the poor
Posted in category:
Publication
Published on:
As a response to the health crises in developing countries and the insufficient access to affordable drugs, around 90 of what are known as Global Public-Private Partnerships (GPPPs) have been set up over the last decade. Although these partnerships are varied, they all share some basic characteristics. They form collaborations or partnerships made up of a United Nations (UN) body such as the World Health Organization (WHO), national governments, corporations, foundations and non-governmental organisations (NGOs). The world’s largest pharmaceutical companies are also involved in these partnerships, and they provide drugs to the partnerships, usually at a reduced price or as a donation.
Partners
-
Wemos
Publication
Related news
-
The Telenor Myanmar scandal: a stark warning for data control in authoritarian timesPosted in category:Opinion
Joseph Wilde-RamsingPublished on:
Joseph Wilde-Ramsing -
Levi’s sued over misleading claims on labour conditionsPosted in category:News
Aintzane MárquezPublished on: -
Investor protection blocking climate actionPosted in category:Opinion
Bart-Jaap VerbeekPublished on:
Bart-Jaap Verbeek
